Latest Ratios: P/E Ratio 21.5x · EV/EBITDA 1.1x · ROE 1.6%. (2018–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $67M | $89M | $134M | $67M | $86M | $400M | $839M | $310M | — |
| Enterprise Value | $32M | $53M | $112M | $66M | $97M | $377M | $819M | $309M | — |
| P/E Ratio → | 21.55 | 45.58 | 17.53 | — | — | — | 21.64 | — | — |
| P/S Ratio | 0.39 | 0.51 | 0.73 | 0.36 | 0.40 | 2.07 | 5.18 | 2.15 | — |
| P/B Ratio | 0.32 | 0.68 | 1.12 | 0.65 | 0.75 | 3.03 | 28.65 | 1.34 | — |
| P/FCF | 5.00 | 6.61 | 5.35 | 6.07 | — | 26.36 | 22.11 | 265.60 | — |
| P/OCF | 2.58 | 3.41 | 3.65 | 2.93 | — | 17.30 | 21.38 | 49.20 | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.31 | 0.61 | 0.35 | 0.45 | 1.95 | 5.06 | 2.14 | — |
| EV / EBITDA | 1.15 | 1.93 | 3.53 | — | — | — | 18.13 | 26.99 | — |
| EV / EBIT | 2.69 | 4.55 | 7.60 | 11.08 | — | — | 19.88 | 49.15 | — |
| EV / FCF | — | 3.96 | 4.48 | 5.96 | — | 24.85 | 21.59 | 265.01 | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 87.3% | 87.3% | 95.1% | 93.3% | 92.9% | 95.9% | 95.3% | 95.1% | 93.8% |
| Operating Margin | 6.7% | 6.7% | 8.0% | -9.8% | -32.3% | -4.2% | 25.5% | 4.4% | 16.0% |
| Net Profit Margin | 1.1% | 1.1% | 4.1% | -5.3% | -53.8% | 31.3% | 24.0% | -0.3% | 14.2% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROE | 1.6% | 1.6% | 6.8% | -9.1% | -94.0% | 74.9% | 29.8% | -0.3% | 47.7% |
| ROA | 1.1% | 1.1% | 4.4% | -5.4% | -41.1% | 28.8% | 25.3% | -0.2% | 29.9% |
| ROIC | 9.1% | 9.1% | 11.1% | -12.2% | -44.5% | -10.3% | 25.8% | 3.9% | — |
| ROCE | 7.7% | 7.7% | 10.4% | -12.9% | -29.0% | -4.6% | 29.1% | 4.4% | 53.2% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.20 | 0.20 | 0.25 | 0.32 | 0.34 | 0.34 | 0.01 | 0.00 | 0.17 |
| Debt / EBITDA | 0.96 | 0.96 | 0.95 | — | — | — | 0.00 | 0.02 | 0.29 |
| Net Debt / Equity | — | -0.27 | -0.18 | -0.01 | 0.09 | -0.17 | -0.67 | -0.00 | -0.68 |
| Net Debt / EBITDA | -1.30 | -1.30 | -0.69 | — | — | — | -0.44 | -0.06 | -1.12 |
| Debt / FCF | — | -2.65 | -0.87 | -0.12 | — | -1.51 | -0.52 | -0.59 | -1.32 |
| Interest Coverage | — | — | — | — | — | — | — | — | — |
Net cash position: cash ($62M) exceeds total debt ($27M)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.34 | 2.34 | 2.28 | 1.53 | 1.19 | 2.62 | 1.47 | 11.89 | 1.60 |
| Quick Ratio | 2.34 | 2.34 | 2.28 | 1.53 | 1.19 | 2.62 | 1.47 | 52.44 | 1.60 |
| Cash Ratio | 1.72 | 1.72 | 1.71 | 1.02 | 0.62 | 1.79 | 0.86 | 9.23 | 1.46 |
| Asset Turnover | — | 0.92 | 1.01 | 1.13 | 1.08 | 0.53 | 3.00 | 0.57 | 2.11 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | 30.75 | 19.90 | 21.66 | 29.53 | 33.17 | 21.27 | 9.94 | 4.89 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 4.5% | 2.1% | 5.7% | 6.3% | 2.9% | 4.8% | 2.6% | 5.0% | — |
| Payout Ratio | 97.7% | 97.7% | 100.6% | — | — | 31.5% | 56.5% | — | 79.6% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 4.6% | 2.2% | 5.7% | — | — | — | 4.6% | — | — |
| FCF Yield | 20.0% | 15.1% | 18.7% | 16.5% | — | 3.8% | 4.5% | 0.4% | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 1.4% | 0.0% | 0.5% | — |
| Total Shareholder Yield | 4.5% | 2.1% | 5.7% | 6.3% | 2.9% | 6.1% | 2.7% | 5.5% | — |
| Shares Outstanding | — | $108M | $97M | $93M | $85M | $67M | $66M | $31M | $7M |
Regulatory and cyclical saturation
According to current market data, MAPS trades at a P/S ratio of 0.39 and an EV/EBITDA of 1.15, suggesting that investors are heavily discounting the company's future growth prospects due to the persistent revenue contraction and the inherent regulatory risks associated with the cannabis technology sector.
The low valuation multiples appear to indicate that the market views the company as a distressed asset rather than a high-growth SaaS platform. This pricing suggests that investors are skeptical of the company's ability to return to top-line expansion, effectively pricing in a permanent impairment of the business model's long-term potential.
Based on reported figures, the company's ROIC has trended downward to 0.1% in 2026Q1, a significant decay from the 3.9% peak observed in 2024Q3, which highlights the firm's ongoing struggle to generate meaningful returns on its invested capital amidst a challenging and contracting operational environment.
The erosion of ROIC suggests that the capital deployed into the business is failing to generate adequate economic value, likely due to the combination of high operating costs and stagnant revenue. This trend warrants further investigation into whether the company's past acquisitions are providing the intended synergies or if they are merely weighing down the return profile.
As reported in financial statements, the company's asset turnover ratio has remained stagnant at approximately 0.23 in 2026Q1, indicating that the firm is struggling to extract higher revenue from its existing asset base, which is further complicated by inconsistent management of its accounts receivable cycle.
The lack of improvement in asset turnover suggests that the company's infrastructure is not scaling efficiently with its current revenue levels. Investors should monitor the DSO trends, as any further lengthening of collection periods could signal deteriorating credit quality among the company's retail client base.
Based on the company's reported figures, the debt-to-equity ratio has improved to 0.19 in 2026Q1 from 0.32 in 2023Q4, demonstrating a disciplined approach to capital structure that provides a necessary cushion against the volatility inherent in the cannabis industry's current regulatory and economic climate.
While the low leverage profile is a positive indicator of financial health, it also reflects the company's limited access to traditional debt markets. This conservative stance appears prudent given the current lack of consistent free cash flow, which would otherwise make servicing higher debt levels a significant risk.
Analysts frequently misapply standard SaaS valuation multiples to MAPS, failing to account for the unique regulatory constraints and the high bad-debt risk inherent in the cannabis retail sector, which obscures the true quality of the company's recurring revenue streams compared to mainstream software peers.
Using traditional P/S or EV/EBITDA multiples without adjusting for the 'cannabis discount' and the provision for doubtful accounts leads to an incomplete assessment of the company's risk-adjusted value. A more appropriate approach would involve evaluating the company based on its cash-conversion efficiency and the durability of its retailer network rather than simple top-line growth multiples.
Includes 30+ ratios · 8 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying MAPS stock.
WM Technology, Inc.'s current P/E ratio is 21.5x. The historical average is 28.3x. This places it at the 33th percentile of its historical range.
WM Technology, Inc.'s current EV/EBITDA is 1.1x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 12.6x.
WM Technology, Inc.'s return on equity (ROE) is 1.6%. The historical average is 7.2%.
Based on historical data, WM Technology, Inc. is trading at a P/E of 21.5x. This is at the 33th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
WM Technology, Inc.'s current dividend yield is 4.54% with a payout ratio of 97.7%.
WM Technology, Inc. has 87.3% gross margin and 6.7% operating margin.
WM Technology, Inc.'s Debt/EBITDA ratio is 1.0x, indicating low leverage. A ratio below 2x is generally considered financially healthy.